Fetal-Maternal Monitoring during Pregnancy and Labor: Trends and Opportunities

Dear Colleagues,

Over the past two decades, several improvements in technologies for fetal and neonatal health have been achieved. However, no significant reductions in stillbirths, neonatal deaths, severe brain injuries from hypoxic-ischemic events, and cardiovascular diseases occurred. On the one hand, the complex pathogenesis of perinatal mortality, neonatal brain injury, and congenital heart diseases hamper our understanding of the underpinning of such important aspects. On the other hand, no disruptive technology has emerged, which means that significant advancement in perinatal diagnosis, monitoring, and treatment is still desired. Remarkably, better detection and prevention are needed to advance obstetric and neonatal care around the world. Overall, this requires a multidisciplinary approach across the entire pregnancy care pathway, incorporating perspectives from researchers, clinicians, medical device manufacturers, software developers, and other relevant stakeholders such as policy makers and patient communities.   

The aim of this Special Issue of Bioengineering is to represent the research, along with the associated challenges and opportunities, for innovative methods and technologies for fetal-maternal monitoring, diagnostics and therapeutics during pregnancy, labor, and delivery. We are excited to provide a view from both academic institutions and the industry spanning all stakeholders, from both researchers and device/algorithm developers as well as the voices of the clinical care providers and the patients.

Topics covered will include but are not limited to,

• advances in the physiological and clinical understanding of fetal development and pathogenesis of perinatal mortality
• fetal heart monitoring using cardiotocography and maternal abdominal electrocardiogram
• fetal neurodevelopment
• new medical devices for perinatal care
• signal processing techniques
• artificial intelligence applications
• regulatory aspects
• challenges in the development of large-scale predictive models of fetal compromise throughout the entire pregnancy.

Dr. Aimée Lovers
Dr. Giulia Baldazzi
Dr. Nicolò Pini
Dr. Danilo Pani
Dr. Antoniya Georgieva
Prof. Dr. Patrice Abry
Dr. Martin Gerbert Frasch
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.